Immunology and Microbiology
Influenza Virus
83%
Influenza
63%
Influenzavirus A
46%
Hemagglutinin
46%
Severe Acute Respiratory Syndrome Coronavirus 2
43%
Immunology
38%
interferon
36%
Viral Disease
35%
Influenza Vaccine
31%
Influenza A Virus (H1N1)
22%
Antibody Response
21%
Human Immunodeficiency Virus 1
21%
COVID-19
21%
Epitope
19%
Immune Response
19%
Immunity
19%
Neutralizing Antibody
18%
Virus
18%
Viral Replication
16%
Glycoprotein
14%
Monoclonal Antibody
14%
Innate Immune System
14%
Spike
14%
Human Immunodeficiency Virus
12%
Infectious Agent
12%
Influenza B Virus
12%
Newcastle Disease Virus
11%
Ebola Virus
10%
T Cell
10%
Neutralization
10%
RNA Virus
10%
Titer
9%
Antibodies
9%
Wild Type
9%
Influenza A Virus (H5N1)
9%
B Cell
9%
Dendritic Cell
8%
Receptor Binding
8%
Nucleoprotein
8%
Viral Protein
8%
Influenza Virus Hemagglutinin
8%
Virus Strain
7%
Gene Expression
7%
Immunogenicity
7%
Influenza A Virus (H3N2)
7%
Humoral Immunity
7%
Bird
7%
Mouse Model
6%
Cytotoxic T-Cell
6%
Mustela Putorius Furo
6%
Cytokine
6%
RIG-I
6%
Pig
6%
Recombinant Virus
6%
Host Cell
6%
Lineages
5%
Adoptive Immunity
5%
Paramyxoviridae
5%
Virion
5%
Promoter Region
5%
Reassortment
5%
Cladistics
5%
Virus Hemagglutinin
5%
Virus Genome
5%
Keyphrases
Influenza Virus
100%
Virus
68%
COVID-19
56%
Hemagglutinin
34%
Vaccination
23%
Influenza-like Illness
22%
Influenza
21%
Influenza Vaccine
19%
Interferon-α (IFN-α)
19%
Antibody Response
17%
Viral
16%
Neuraminidase
15%
Human Immunodeficiency Virus Type 1 (HIV-1)
13%
Monoclonal Antibody
13%
Ebola Virus
12%
Epitope
12%
Influenza B Virus
12%
Neutralizing Antibodies
12%
Hemagglutinin Stalk
11%
Immune Response
11%
NS1 Protein
10%
Innate Immune Response
10%
Recombinant
10%
Type I Interferon
10%
NS1′
10%
Newcastle Disease Virus
10%
Universal Vaccine
10%
Influenza A
9%
Retinoic Acid-inducible Gene I (RIG-I)
9%
Specific Antibodies
8%
SARS-CoV-2 Infection
8%
Stalk Domain
8%
Influenza Virus Hemagglutinin
8%
Virus Infection
8%
Vaccine Candidate
7%
Nucleoprotein
7%
Pregenomic RNA (pgRNA)
7%
Viral Infection
7%
H1N1
7%
Antiviral Activity
7%
Infected Cells
7%
Chimeric Hemagglutinin
7%
Viral Replication
6%
Virus Replication
6%
Antiviral Response
6%
Pandemic Influenza Virus
6%
Immunization
6%
Ferret
6%
Mouse Model
6%
Non-structural Protein
6%
Immunogenicity
6%
Nipah Virus
6%
1918 Influenza Pandemic
6%
Vaccine Response
6%
Reverse Genetics
6%
Virulence
6%
Lung
6%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
6%
Dendritic Cells
6%
VP35
5%
Avian Influenza
5%
Interferon Response
5%
B Cells
5%
Titer
5%
Adjuvanted
5%
Broadly Protective
5%
Zika Virus
5%
Viral Proteins
5%
Spike Protein
5%
Receptor-binding Domain
5%
Recombinant Virus
5%